Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Clinical and Economic Burden Among Patients with Chronic Lymphocytic Leukemia Using a Novel Real-World Patient-Centered Database

Deborah Kuk, Brian Chen, Naga Samyukta, Valmeek Kudesia, Richard Tsai, Stuart L. Goldberg

Blood (2023) 142 (Supplement 1): 7356.

https://doi.org/10.1182/blood-2023-180792

Published: 2023

Journal Articles

Autologous Transplant, and Not ATO Alone, Remains the Preferred Therapy for Relapsed APL: A Report from the CIBMTR, EBMT and Two Specialized Centers

Chezi Ganzel, Vikram Mathews, DM, Kamran Alimoghaddam, MD, Ardeshir Ghavamzadeh, MD, Deborah Kuk, ScM, Sean Devlin, PhD, Hailin Wang, Daniel Weisdorf, MD, Dan Douer, MD, Jacob M. Rowe, MD, Arnon Nagler, MD MSc, Mohamad Mohty, Martin S. Tallman, MD, Jordi Estev, Mei-Jie Zhang

Blood (2015) 126 (23): 928.

https://doi.org/10.1182/blood.V126.23.928.928

Published: 2015

Journal Articles

Outcomes of Inferior Vena Cava Filter Placement in a Large Population of Cancer Patients Diagnosed with Pulmonary Embolism: Risk for Recurrent Venous Thromboembolism, Survival, and Filter-Related Complications

Catherine C. Coombs, MD, Deborah Kuk, ScM, Sean Devlin, PhD, Robert Siegelbaum, MD, Rekha Parameswaran, MD, Simon Mantha, MD MPH, Gerald A Soff, MD

Blood (2015) 126 (23): 1112.

https://doi.org/10.1182/blood.V126.23.1112.1112

Published: 2015

Journal Articles

Multiparameter Flow Cytometry For Detection Of Minimal Residual Disease In Multiple Myeloma After T-Cell Depleted Allogeneic Stem Cell Transplant

Satyajit Kosuri, MD, Katherine M Smith, BA, Deborah Kuk, MS, Sean M. Devlin, PhD, Peter G. Maslak, M.D., Sergio Giralt, MD, Guenther Koehne, MD, PhD

Blood (2013) 122 (21): 4647.

https://doi.org/10.1182/blood.V122.21.4647.4647

Published: 2013

Journal Articles

Poor Graft Function in Recipients of T Cell Depleted (TCD) Allogeneic Hematopoietic Stem Cell Transplants (HSCT) Is Mostly Related to Viral Infections and Anti-Viral Therapy.

Roni Tamari, MD, Sheetal Ramnath, Deborah Kuk, MS, Craig S. Sauter, MD, Doris M Ponce, MD, Sean Devlin, PhD, James W. Young, MD, Sergio Giralt, MD, Hugo R Castro-Malaspina, MD

Blood (2012) 120 (21): 3147.

https://doi.org/10.1182/blood.V120.21.3147.3147

Published: 2012

Journal Articles

A Phase II Trial of Peri-Transplant Palifermin with Busulfan, Melphalan and Fludarabine Followed by T-Cell Depleted Hematopoietic Stem Cell Transplants in Patients with Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Evolved From MDS

Roni Tamari, MD, Sheetal Ramnat Sheetal, Deborah Kuk, MS, Esperanza B. Papadopoulos, MD, Ann A. Jakubowski, MD, PhD, Farid Boulad, MD, Trudy N. Small, MD, Nancy A. Kernan, MD, Miguel A Perales, MD, Guenther Koehne, MD, PhD, Doris M Ponce, MD, Sean Devlin, PhD, Jenna D Goldberg, MD, James W. Young, MD, Sergio A Giralt, MD, Richard J. O'Reilly, MD, Hugo R Castro-Malaspina, MD

Blood (2012) 120 (21): 1935.

https://doi.org/10.1182/blood.V120.21.1935.1935

Published: 2012

NARROW

Clinical and Economic Burden Among Patients with Chronic Lymphocytic Leukemia Using a Novel Real-World Patient-Centered Database

Autologous Transplant, and Not ATO Alone, Remains the Preferred Therapy for Relapsed APL: A Report from the CIBMTR, EBMT and Two Specialized Centers

Outcomes of Inferior Vena Cava Filter Placement in a Large Population of Cancer Patients Diagnosed with Pulmonary Embolism: Risk for Recurrent Venous Thromboembolism, Survival, and Filter-Related Complications

Multiparameter Flow Cytometry For Detection Of Minimal Residual Disease In Multiple Myeloma After T-Cell Depleted Allogeneic Stem Cell Transplant

Poor Graft Function in Recipients of T Cell Depleted (TCD) Allogeneic Hematopoietic Stem Cell Transplants (HSCT) Is Mostly Related to Viral Infections and Anti-Viral Therapy.

A Phase II Trial of Peri-Transplant Palifermin with Busulfan, Melphalan and Fludarabine Followed by T-Cell Depleted Hematopoietic Stem Cell Transplants in Patients with Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Evolved From MDS

Email alerts

ASH Publications

American Society of Hematology

Clinical and Economic Burden Among Patients with Chronic Lymphocytic Leukemia Using a Novel Real-World Patient-Centered Database

Autologous Transplant, and Not ATO Alone, Remains the Preferred Therapy for Relapsed APL: A Report from the CIBMTR, EBMT and Two Specialized Centers

Outcomes of Inferior Vena Cava Filter Placement in a Large Population of Cancer Patients Diagnosed with Pulmonary Embolism: Risk for Recurrent Venous Thromboembolism, Survival, and Filter-Related Complications

Multiparameter Flow Cytometry For Detection Of Minimal Residual Disease In Multiple Myeloma After T-Cell Depleted Allogeneic Stem Cell Transplant

Poor Graft Function in Recipients of T Cell Depleted (TCD) Allogeneic Hematopoietic Stem Cell Transplants (HSCT) Is Mostly Related to Viral Infections and Anti-Viral Therapy.

A Phase II Trial of Peri-Transplant Palifermin with Busulfan, Melphalan and Fludarabine Followed by T-Cell Depleted Hematopoietic Stem Cell Transplants in Patients with Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Evolved From MDS

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only